Study Providing Monotherapy (Sitaxsentan) And Combination Therapy (Sitaxsentan+Sildenafil) To Subjects With Pulmonary Arterial Hypertension (PAH) To Assess Long-Term Safety
Clinical trial NCT00796510 · TERMINATED
Trial details
- NCT number
- NCT00796510
- Sponsor
- Pfizer
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-07-01
- Primary completion
- 2011-01-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.